Torres-Bonilla Gisela MD - 33578 Riverview, FL

Business Name: Torres-Bonilla Gisela MD
Categorized In: Doctors
Address: 7229 Us Highway 301 South, Riverview, FL 33578
Phone Number: (813) 977-3600
Contact Person: Gisela Torres-Bonilla
Website Address: ecdss.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: We Care Pediatrics - Riverview, FL 33578
Baker Mark B MD - Riverview, FL 33578
Rapado Viera Ivan MD - Riverview, FL 33578
Trzmielina Sonia D MD - Riverview, FL 33578
Sandhu Ravneet MD - Riverview, FL 33578
Beach-Reber Pamela J MD - Riverview, FL 33578
Anglin Mickel MD - Riverview, FL 33578
Demetriou, Nektarios S DO - Riverview, FL 33578
Ayala Raul MD - Riverview, FL 33578
Alver James E MD - Riverview, FL 33578
Paola Angelo MD - Riverview, FL 33578
Cheeseman III George R MD - Riverview, FL 33578
Anglin Medical Family & Sports - Riverview, FL 33578
Ordman Stanley A MD - Riverview, FL 33578
Martin Sandy MD - Riverview, FL 33578
Romagnolo Stephen C MD - Riverview, FL 33578
Proper Steven A MD - Riverview, FL 33578
Bay Area Cardiology Assoc Inc - Riverview, FL 33578
Schreier Joseph E DO - Riverview, FL 33578
Collaborative Therapeutic Services LLC - Riverview, FL 33578

Torres-Bonilla Gisela MD provides professional Doctors from its single location at the coordinates 27.87597,-82.32684.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 7229 Us Highway 301 South, Riverview, Florida 33578 or contacted through representative Gisela Torres-Bonilla at (813) 977-3600.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Torres-Bonilla Gisela MD through its company website at ecdss.com. Engage with this business on its social media platforms through on Twitter and on Facebook.